Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...
Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...
An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...
A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .
The door may now be open for additional challenges to patents covering mRNA vaccine technologies, paving the way for increased competition in the ...
HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...
A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make ...
Moderna – at the moment embroiled in a patent dispute with Pfizer and BioNTech over mRNA intellectual property – is also testing a vaccine that combines COVID-19 and flu in a single jab in a ...
Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly illnesses. That's why there's a specific immunization schedule laid out by ...
The FDA already has cleared COVID-19 vaccines tweaked to better target omicron as boosters for everyone 5 and older. Pfizer's says its COVID-19 vaccine was 73% effective in protecting children ...